Malaria in South America: The Target is Close

نویسندگان

  • Virgilio E. Failoc-Rojas
  • Carolina Molina-Ayasta
چکیده

The article published by Quispe and others outlines Peru’s three strategic plans to eliminate malaria in the Peruvian Amazon region. It is a significant achievement for Peru to implement a plan to eradicate malaria in the Amazon region, where the greater percentages of cases of malaria in Peru are concentrated. Malaria has devastating effects on the health and way of life of the people all over the world; however, it can be prevented and treated. In America, cases of malaria have been reduced by 58%, and malaria deaths have decreased by 70% since 2000. These figures are very encouraging and represent a starting point from which to propose new longterm goals for the eradication of malaria. To analyze the current situation in Peru compared with the rest of South America, we created a chart using World Health Organization data on cases of malaria and the total population, analyzing the incidences by year (Figure 1). In South America (excluding Guyana, Suriname, and French Guyana), three countries (Argentina, Ecuador, and Paraguay) have achieved the preelimination phase. Peru appears to be the only country that has not been able to significantly reduce its cases of malaria, with 249.57 per 100,000 inhabitants in 2000 compared with 220.58 cases per 100,000 inhabitants in 2015, which indicates that Peru has neither kept up with nor applied the strategies used by its neighboring countries. Venezuela, Bolivia, and Brazil have gradually reduced their incidences of malaria during this period of time. Multidisciplinary strategies for the control of malaria must be continued, from hygiene education for the community and better access to medication, to the creation of vaccines to interrupt the spread of malaria and the strengthening of the economic political strategies of malaria-endemic countries such as Peru. VIRGILIO E. FAILOC-ROJAS

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clinical Pharmacology of the Antimalarial Quinine in Children

Quinine is the best studied drug for treating severe malaria in very young children. Quinine may be administered in pregnancy and, at therapeutic doses, malformations have not been reported. Some strains of quinine from Southeast Asia and South America have become resistant. Quinine is the treatment of choice for the drug-resistant severe Plasmodium falciparum. The antimalarial mechanism of qui...

متن کامل

Malaria drug - resistance in Iran

Introduction: Malaria is a public health problem for approximately 2.4 billion people, 40% of the world’s population, particularly in the tropical and subtropical countries. Countries in Asia, and Latin America, the islands of the South, West, and central pacific ocean are all affected. Drug resistance is the greatest challenge in combating against malaria. Drug resistance in malaria is now w...

متن کامل

Clinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children

In 2010, there were estimated 219 million cases of malaria resulting in 666,000 deaths and two-thirds were children. Children are more vulnerable than adults to malaria parasites. In sub-Saharan African countries, maternal malaria is associated with up to 200,000 estimated infant deaths yearly. Malaria is caused by five Plasmodium parasites namely: Plasmodium falciparum, Plasmodium vivax, Plasm...

متن کامل

گزارش 1 مورد مالاریای القایی در معتاد تزریقی

Malaria is a protozoal disease. It has four species (P. Falciparum, P. Vivax, P. Ovale, P. Malariae) that each produces disease in humans. Malaria is transmitted by female Anopheles bite to human. It can also be transmitted by blood transfusion or contaminated needle. Iran is divided to 3 zones for transmission of malaria: 1- north of Zagros mountain, 2- south and south-west, 3- so...

متن کامل

مروری بر وضعیت مالاریا در ایران

Malaria has been prevalent for a long time in Iran. About 1000 years ago, the Iranian physicians such as Avicenna (979-1037) were acquainted to the clinical feature of the disease. The scientific study of malaria in Iran was started by Latycheve in 1921. Later on up to 1944, malaria have been studied by some Iranian and foreign investigators and it was found hyper-endemic in some littoral parts...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 95  شماره 

صفحات  -

تاریخ انتشار 2016